@article {1532325,
	title = {An update on autoimmune retinopathy},
	journal = {Indian J Ophthalmol},
	volume = {68},
	number = {9},
	year = {2020},
	month = {2020 Sep},
	pages = {1829-1837},
	abstract = {Autoimmune retinopathy (AIR) refers to a group of rare autoimmune retinal degenerative diseases presumably caused by cross-reactivity of serum autoantibodies against retinal antigens. The pathogenesis of AIR remains largely presumptive and there are a significant number of antiretinal antibodies that have been detected in association with AIR. The diagnosis of AIR is largely based on the demonstration of antiretinal antibodies in the serum along with suggestive clinical features and ancillary investigations. A high index of suspicion along with early diagnosis and treatment may play a critical role to lower the risk of irreversible immunological damage to the retinal cells in these patients. A multi-disciplinary approach for complete management and evaluation is helpful in such conditions. Various therapeutic options have been described for the treatment of AIR, though there is no consensus on standard treatment protocol.},
	issn = {1998-3689},
	doi = {10.4103/ijo.IJO_786_20},
	author = {Dutta Majumder, Parthopratim and Marchese, Alessandro and Pichi, Francesco and Garg, Itika and Agarwal, Aniruddha}
}
